Statin Adherence: Does Gender Matter?

dc.contributor.author

Goldstein, Karen M

dc.contributor.author

Zullig, Leah L

dc.contributor.author

Bastian, Lori A

dc.contributor.author

Bosworth, Hayden B

dc.date.accessioned

2024-01-31T00:49:21Z

dc.date.available

2024-01-31T00:49:21Z

dc.date.issued

2016-11

dc.description.abstract

Purpose of review

Cardiovascular disease (CVD) continues to be the leading cause of death for men and women in the USA. Statins have contributed significantly to noted declines in cardiovascular-related mortality in the last decade; however, the benefit of statins is inequitable across genders. Women continue to be less likely to take statins and to meet target LDL goals than men. As a possible contributing factor to this disparity, we explore the evidence for gender-based differences in provision of, and adherence to statins.

Recent findings

Compared with men, women are less likely to adhere to statins. Potential reasons for this gender difference in use of statins can be observed across all phases of adherence including both intentional and unintentional non-adherence. Notable gender-specific contributing factors for statin non-adherence include decreased provider and patient awareness of CVD risk among women, higher risk of statin intolerance among women, and competing demands associated with family caregiving responsibilities. Similar to limitations in the broader CVD literature, there is inadequate inclusion of gender-specific analyses in statin-related trials. Gender-based disparities in statin adherence can be linked to both provider level, psychosocial, and medication intolerance factors. Interventions designed to improve statin adherence should take gender-specific challenges into consideration such as women being older at the time of increased CVD risk, higher rates of statin intolerance, and potentially greater caregiving responsibilities.
dc.identifier

10.1007/s11883-016-0619-9

dc.identifier.issn

1523-3804

dc.identifier.issn

1534-6242

dc.identifier.uri

https://hdl.handle.net/10161/29911

dc.language

eng

dc.publisher

Springer Science and Business Media LLC

dc.relation.ispartof

Current atherosclerosis reports

dc.relation.isversionof

10.1007/s11883-016-0619-9

dc.rights.uri

https://creativecommons.org/licenses/by-nc/4.0

dc.subject

Humans

dc.subject

Cardiovascular Diseases

dc.subject

Hydroxymethylglutaryl-CoA Reductase Inhibitors

dc.subject

Sex Characteristics

dc.subject

Medication Adherence

dc.title

Statin Adherence: Does Gender Matter?

dc.type

Journal article

duke.contributor.orcid

Goldstein, Karen M|0000-0003-4419-5869

duke.contributor.orcid

Zullig, Leah L|0000-0002-6638-409X

duke.contributor.orcid

Bosworth, Hayden B|0000-0001-6188-9825

pubs.begin-page

63

pubs.issue

11

pubs.organisational-group

Duke

pubs.organisational-group

School of Medicine

pubs.organisational-group

Basic Science Departments

pubs.organisational-group

Clinical Science Departments

pubs.organisational-group

Institutes and Centers

pubs.organisational-group

Medicine

pubs.organisational-group

Psychiatry & Behavioral Sciences

pubs.organisational-group

Medicine, General Internal Medicine

pubs.organisational-group

Duke Cancer Institute

pubs.organisational-group

Duke Clinical Research Institute

pubs.organisational-group

Institutes and Provost's Academic Units

pubs.organisational-group

Center for the Study of Aging and Human Development

pubs.organisational-group

Initiatives

pubs.organisational-group

Duke Science & Society

pubs.organisational-group

Population Health Sciences

pubs.organisational-group

Duke Innovation & Entrepreneurship

pubs.organisational-group

Psychiatry & Behavioral Sciences, Behavioral Medicine & Neurosciences

pubs.organisational-group

Duke - Margolis Center For Health Policy

pubs.publication-status

Published

pubs.volume

18

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
s11883-016-0619-9.pdf
Size:
452.8 KB
Format:
Adobe Portable Document Format